Sept. 4, 2019 Price forecast | 2 weeks: 2.29% | 1 month: 2.50% | 3 months: 1.57%

ELAN stock forecast

Our latest prediction for Elanco Animal Health, Inc.'s stock price was made on the Sept. 4, 2019 when the stock price was at 26.36$.

In the short term (2weeks), ELAN's stock price should outperform the market by 2.29%. During that period the price should oscillate between -4.05% and +6.17%.

In the medium term (3months), ELAN's stock price should outperform the market by 1.57%. During that period the price should oscillate between -9.85% and +15.58%.

Create a solid portfolio with ELAN

Add ELAN to your portfolio and optimize it!

About Elanco Animal Health, Inc.

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.

At the moment the company generates 2802M USD in revenues.

On its last earning announcement, the company reported a loss of -0.25$ per share.

The book value per share is 14.21$

Elanco Animal Health, Inc. website

Three months stock forecastSept. 4, 2019


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
2802M 50.10% 214M 7.60% -101M -0.25 - - 391M 14.21 330M -182M 147M